Beginner's Mind

In today’s episode, we explore Clinical Development with Ole Dammann, the owner of KFGN, a group of 6 clinical trial sites in Germany, and after joining Pratia, several sites in Eastern Europe. Ole Dammann is one of the best experts in clinical trial management in the LSG2G Community. Ole is currently working on the digitization of clinical research and the development of new business models. In t...

In this conversation, I will talk with Peter Llewellyn-Davies, CEO of Apeiron and President of Biotech Austria about the Future of Life Science Entrepreneurship and Investment in Europe. Topics we discuss in the show: The Development of the Life Science Eco-System in Europe How Family Offices Support Life Science Companies in Europe How to Translate Science into Business Does Europe Have a Culture...

In this conversation, I will talk with Oliver Mavher and Michael Deichsel about Crypto Trading and taxes. Topics we discuss in the show: The questions that I consider relevant for everybody owning digital assets: What if someone gets paid in Bitcoin or other Cryptocurrencies? Is that a taxable event? What if someone invests in those novel digital assets and they gain in value? Does the location of...

In this conversation, we will talk about the future of the Early-Stage Ecosystem in Europe. Speaker in the Episode: Alexander Schwartz joined IST cube in 2018 as a Partner. He has more than 15 years of experience in management consulting, eight of which with McKinsey & Company. Ingrid Kelly Spillman joined the IST Tech Transfer team in October 2018. Ingrid worked as a patent attorney in and fo...

The industry gains complexity, and I am happy that a speaker from the LSG2G community has dedicated time to speak about the Future of the Food Industry. Speaker in the Episode: Dr. Caroline E. Heil Since Jul. 1, 2021, Caroline has been CEO of The New Meat Company AG, a young stock-listed, purpose-driven impact investment company in Berlin focusing on alternative proteins.  Caroline is intrigued by...

Tech Transfer describes the process to bring scientific inventions from the discovery stage into companies for translational and clinical R&D. To gain more insights into this area, I invited a tech transfer expert from the LSG2G Community to this conversation. Speaker in this Episode is Saara Inkinen, Nordic Catalyst. Dr. Inkinen is a technology transfer and innovation management specialist ba...

In this conversation, we discuss the development of the European Pharma Eco-System, different business models, and what it takes to lead a company to success. Today’s speaker is Dimitrios Tzalis. In the 90s, he received a Ph. D. from the University of California, San Diego, a Master of Science in Chemistry from the University of Chicago, and a Master of Science in Biochemistry from Ball State Univ...

Here is my conversation with Andrea Sommer about the advantages of patents for private deep-tech companies. Timestamps: For those who want to listen to specific parts of the episode, here are the timestamps: 00:00 Opening Christian Soschner 02:00 Intro Andrea Sommer – Importance of Patents 03:48 The Role of Patents in Deep Tech Companies – Understanding the Importance of Patent Processes 13:51 Wha...

Here is my conversation with Kurt Höller and Joy Cürten from EIT Health about the health tech revolution in Europe and the Rest of the World. Episode Links: Article to the Episode: https://lsg2g.substack.com/p/eit-health-and-the-international-514 Youtube:  https://youtu.be/OnQrvbgcO8Y Kurt Höller: https://www.linkedin.com/in/hoeller/ Joy Cürten: https://www.linkedin.com/in/joy-c%C3%BCrten-a8977241...

Here is my conversation with Sebastien Groyer , Entrepreneur and Venture Capitalist Episode Links: Article to the Episode: https://lsg2g.substack.com/p/7-tales-from-20-years-of-deep-tech-42f Youtube: https://youtu.be/Ni3mEDM7-_c Sebastien Groyer: https://www.linkedin.com/in/sebastien-groyer-2438548/ Podcast Links: Podcast Website: https://www.lifescienceget2gether.com/ Community Partner: https://l...

Here is my conversation with Wolfgang Kienreich , CBO of Know-Center. Episode Links: Article to the Episode: https://lsg2g.substack.com/p/46-an-introduction-to-know-center Youtube: https://youtu.be/eTU5zROX5E4 Wolfgang Kienreich: https://www.linkedin.com/in/wolfgang-kienreich-8350b899/ Know Center: https://www.linkedin.com/company/know-center/ Podcast Links: Podcast Website: https://www.lifescienc...

Here is my conversation with Jama Nateqi, CEO of Symptoma. Episode Links: Article to the Episode: https://lsg2g.substack.com/p/45-hidden-secrets-to-successful-entrepreneurship Youtube: https://youtu.be/VOBc7pfqWOI Jama Nateqi: https://www.linkedin.com/in/jama-nateqi/ Symptoma: https://www.linkedin.com/company/symptoma/ Podcast Links: Podcast Website: https://www.lifescienceget2gether.com/ Communit...

Here is the conversation with Tero Weckroth, Business Angel and Investment Expert from Finland about Public and Private Investments. Episode Links: Article to the Episode: https://lsg2g.substack.com/p/44-private-and-public-investments Video to the Episode: https://youtu.be/7WDHWOyaPQQ Tero Weckroth: https://www.linkedin.com/in/tero-weckroth-5b927/ Chessboxing: https://www.nordicchessboxing.com/ Po...

Thomas Moser and Tilmann Buerckstuemmer lead the Austrian Life Science Company Aelian Biotechnology. Episode Links: Article to the Episode: https://lsg2g.substack.com/p/gene-editing-the-next-game-changing-d3f Video to the Episode: https://youtu.be/3bf7ChYUHLE Aelian Biotechnology: https://aelian.bio/ Thomas Moser: https://www.linkedin.com/in/thomas-moser-79819a5/ Tilmann Buerckstuemmer: https://ww...

Have you ever wondered what role the small country Austria - located in the center of Europe - plays in Life Science? Then listen to the managing directors of LISAvienna , Johannes Sarx , and Philipp Hainzl .  LISAvienna is a joint life science platform operated by Austria Wirtschaftsservice and the Vienna Business Agency. On behalf of the Austrian Federal Ministry for Digital and Economic Affairs...

This episode will discuss what it takes to build companies that develop novel therapies, vaccines, and diagnostics in the pharma industry. Since the pandemic, everybody has become familiar with the critical elements of pharma product development. But let’s take a closer look into the value chain of the industry. What does it take to pick up a technology and bring it to patients? Questions we will...

In history, most of the time, humans needed to provide everything they needed to make a living for themselves. Trading goods were part of life but didn’t take up most of the world’s population’s time. Industrialization changed the job profiles, the needs of workers, and the availability of goods. In this century, many people in the western world have jobs to provide services and get what they need...

This podcast episode will discuss the EU’s next framework program for research and innovation, Horizon Europe, and the exciting opportunities this program offers businesses, scientists, and investors. With the launch of the Horizon Europe program just weeks away, we will share insight into the program's novelties, where to start, and tips on how to be successful.  The Podcast Host, guests Kim...

In this podcast episode, we will discuss several different forms of growth and scaling up companies. In the era of the fast-growing unicorns and skyrocketing valuations, we try to disassemble the growth path and see what a founder can do to benefit most of these options.  How to decide if an organic or buy&build model is the right one for me?  Are mergers & acquisitions play-field only for...

In this podcast episode, we will discuss how blockchain technology is utilized in the energy sector beyond the well-known utility of a payments system, her experiences in entrepreneurship and innovation, including start-up life in Berlin. Ana Trbovich is the Grid Singularity co-founder & COO and Vice-Chair of the Energy Web Foundation. She serves on UNECE Carbon Neutrality and DENA SET Hub Adv...

It was great fun to talk with Walter Stockinger, Co-Founder of Hadean Ventures, about the topic of Life Science Investments. We covered the following questions: How do Venture Funds operate? What do you need to know about approaching VCs? What is the purpose of a VC? Why are exits necessary for VCs? And what exit strategies are relevant? Why do VCs raise money, and from whom? Use the opportunity t...

This one is an episode for the go-getters and never-giveupers. Astrid and Christian had great fun talking with Essa Saulat, Chief Growth Officer of the Austrian digital health company Symptoma. Essa is a seasoned entrepreneur and helped many start-ups getting off the ground. In this episode, he shares his life story of overcoming adversity, keeping moving forward relentlessly, and ultimately chang...

Drug Development is a challenging process. It needs profound basic research, translating scientific results into products and moving them towards the market. Making things more challenging deal structuring is also a b2b business, which means selling products to the pharma industry that completes the product development and brings therapeutics to patients. How does structuring deals with the pharma...

For more than 10 years, blockchain technology has shaped our economy. The background technology is mostly invisible to average users like me. On the front end, cryptocurrency has hit the news. I remember well the highs of Bitcoin in 2017. And recently, Bitcoin has been rising again. But, and this is something I want to learn, what applications do exist that can improve the life science industries?...

A new year brings new tax rules. Astrid Woollard and Christian Soschner asked the Tax Experts of KPMG Austria to give an update on the newest regulations in Austria. We also had a chance to talk about tax advisors and auditors' roles in the start-up economy. Listen to this episode to learn what's new and when to consult advisors. If you have questions after listening to the episode, reac...